Is Kadmon Pharmaceuticals, LLC FDA approved?

Kadmon Pharmaceuticals, LLC holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does Kadmon Pharmaceuticals, LLC make?

1 product is listed under Kadmon Pharmaceuticals, LLC in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Kadmon Pharmaceuticals, LLC

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 1
Live patents: 5
Exclusivities: 1
Countries: 0

Exclusivity

Patents and exclusivities

Patent	Product	Covers	Expiry
10183931	REZUROCKbelumosudil mesylate	use	Oct 2033
10696660	REZUROCKbelumosudil mesylate	use	Oct 2033
8357693	REZUROCKbelumosudil mesylate	substance, product	Jun 2034
11311541	REZUROCKbelumosudil mesylate	use	Apr 2035
12097202	REZUROCKbelumosudil mesylate	use	Jul 2042

Product	Exclusivity	Until
REZUROCKBELUMOSUDIL MESYLATE	ODE-362 Orphan drug	Jul 2028

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
Rezurock	belumosudil	tablet, oral	79802-200NDA

Compare

Other companies listing belumosudil

Sanofi12 sites · 3 NDC

Enquiry

Common questions

Is Kadmon Pharmaceuticals, LLC FDA approved?: Kadmon Pharmaceuticals, LLC holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Kadmon Pharmaceuticals, LLC make?: 1 product is listed under Kadmon Pharmaceuticals, LLC in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.